200 related articles for article (PubMed ID: 11134506)
21. Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity.
Zahnd C; Spinelli S; Luginbühl B; Amstutz P; Cambillau C; Plückthun A
J Biol Chem; 2004 Apr; 279(18):18870-7. PubMed ID: 14754898
[TBL] [Abstract][Full Text] [Related]
22. A new yeast display vector permitting free scFv amino termini can augment ligand binding affinities.
Wang Z; Mathias A; Stavrou S; Neville DM
Protein Eng Des Sel; 2005 Jul; 18(7):337-43. PubMed ID: 15976011
[TBL] [Abstract][Full Text] [Related]
23. Selection of scFvs specific for HBV DNA polymerase using ribosome display.
Lee MS; Kwon MH; Kim KH; Shin HJ; Park S; Kim HI
J Immunol Methods; 2004 Jan; 284(1-2):147-57. PubMed ID: 14736425
[TBL] [Abstract][Full Text] [Related]
24. Expression of an antibody fragment at high levels in the bacterial cytoplasm.
Martineau P; Jones P; Winter G
J Mol Biol; 1998 Jul; 280(1):117-27. PubMed ID: 9653035
[TBL] [Abstract][Full Text] [Related]
25. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation.
Ramm K; Gehrig P; Plückthun A
J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351
[TBL] [Abstract][Full Text] [Related]
26. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.
Schier R; Bye J; Apell G; McCall A; Adams GP; Malmqvist M; Weiner LM; Marks JD
J Mol Biol; 1996 Jan; 255(1):28-43. PubMed ID: 8568873
[TBL] [Abstract][Full Text] [Related]
27. Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli.
Pantoliano MW; Bird RE; Johnson S; Asel ED; Dodd SW; Wood JF; Hardman KD
Biochemistry; 1991 Oct; 30(42):10117-25. PubMed ID: 1931943
[TBL] [Abstract][Full Text] [Related]
28. Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.
de Haard HJ; Kazemier B; Koolen MJ; Nijholt LJ; Meloen RH; van Gemen B; Hoogenboom HR; Arends JW
Clin Diagn Lab Immunol; 1998 Sep; 5(5):636-44. PubMed ID: 9729530
[TBL] [Abstract][Full Text] [Related]
29. Analysis of antibody selection by phage display utilizing anti-phenobarbital antibodies.
Malone J; Sullivan MA
J Mol Recognit; 1996; 9(5-6):738-45. PubMed ID: 9174966
[TBL] [Abstract][Full Text] [Related]
30. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
Proba K; Honegger A; Plückthun A
J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980
[TBL] [Abstract][Full Text] [Related]
31. Affinity and folding properties both influence the selection of antibodies with the selectively infective phage (SIP) methodology.
Pedrazzi G; Schwesinger F; Honegger A; Krebber C; Plückthun A
FEBS Lett; 1997 Oct; 415(3):289-93. PubMed ID: 9357985
[TBL] [Abstract][Full Text] [Related]
32. In vitro evolution of single-chain antibodies using mRNA display.
Fukuda I; Kojoh K; Tabata N; Doi N; Takashima H; Miyamoto-Sato E; Yanagawa H
Nucleic Acids Res; 2006; 34(19):e127. PubMed ID: 17012279
[TBL] [Abstract][Full Text] [Related]
33. Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation.
Luginbühl B; Kanyo Z; Jones RM; Fletterick RJ; Prusiner SB; Cohen FE; Williamson RA; Burton DR; Plückthun A
J Mol Biol; 2006 Oct; 363(1):75-97. PubMed ID: 16962610
[TBL] [Abstract][Full Text] [Related]
34. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
Nieba L; Honegger A; Krebber C; Plückthun A
Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169
[TBL] [Abstract][Full Text] [Related]
35. Highly efficient ribosome display selection by use of purified components for in vitro translation.
Villemagne D; Jackson R; Douthwaite JA
J Immunol Methods; 2006 Jun; 313(1-2):140-8. PubMed ID: 16730021
[TBL] [Abstract][Full Text] [Related]
36. Directed evolution for the development of conformation-specific affinity reagents using yeast display.
Weaver-Feldhaus JM; Miller KD; Feldhaus MJ; Siegel RW
Protein Eng Des Sel; 2005 Nov; 18(11):527-36. PubMed ID: 16186140
[TBL] [Abstract][Full Text] [Related]
37. Increased folding stability of TEM-1 beta-lactamase by in vitro selection.
Kather I; Jakob RP; Dobbek H; Schmid FX
J Mol Biol; 2008 Oct; 383(1):238-51. PubMed ID: 18706424
[TBL] [Abstract][Full Text] [Related]
38. Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of thioredoxin.
Jurado P; de Lorenzo V; Fernández LA
J Mol Biol; 2006 Mar; 357(1):49-61. PubMed ID: 16427080
[TBL] [Abstract][Full Text] [Related]
39. Engineering antibody fragments to fold in the absence of disulfide bonds.
Seo MJ; Jeong KJ; Leysath CE; Ellington AD; Iverson BL; Georgiou G
Protein Sci; 2009 Feb; 18(2):259-67. PubMed ID: 19177559
[TBL] [Abstract][Full Text] [Related]
40. Directing phage selections towards specific epitopes.
Parsons HL; Earnshaw JC; Wilton J; Johnson KS; Schueler PA; Mahoney W; McCafferty J
Protein Eng; 1996 Nov; 9(11):1043-9. PubMed ID: 8961357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
